Clinical Trial Update: Fexuprazan for Prevention of Upper Gastrointestinal Bleeding in High Bleeding Risk Patients Receiving Dual Antiplatelet Therapy [NA]

View source ↗

Summary

Clinical trial update introducing fexuprazan to prevent upper gastrointestinal bleeding in high-risk patients on dual antiplatelet therapy; the study is current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Syndrome

Drugs mentioned

• Fexuprazan (fexuprazan)

Snippet

Sponsor: SUK MIN SEO | Conditions: Acute Coronary Syndromes (ACS), Coronary Artery Disease (CAD) | NA | Status: RECRUITING